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activities of SOX9, SOX6, and type II collagen (COL2A1) genes
were determined by luciferase assays in human non-chondrogenic
HeLa cells and mouse chondrogenic ATDC5 cells transfected with
a reporter gene containing the respective promoter fragments.
Protein-DNA binding was examined by electrophoretic mobility
shift assay (EMSA) and chromatin immunoprecipitation (ChIP) as-
say. Chondrogenic differentiation was assessed by endogenous
SOX9, SOX6, and COL2A1 mRNA levels using real-time RT-PCR,
and by Alcian blue staining and alkaline phosphatase activity. For
the functional analyses, we established stable lines of HeLa and
ATDC5 cells with retroviral overexpression of RelA or the control
empty vector (EV). To know the physiological role, we compared
the skeletal phenotypes histologically between homozygous deﬁ-
cient (-/-) mice and the wild-type littermates.
Results: Exhaustive comparison of the sequences of the SOX9
promoters among species found that the 1.0 kb upstream of the
transcriptional start site was about 80% conserved, in which the
binding motifs of nuclear factor kappaB (NF-κB), NFAT, AP-1, Sp-1,
CREB, CCAAT, and GATA were identiﬁed. When expression vec-
tors of 31 putative transcription factors for the seven identiﬁed mo-
tifs were co-transfected in HeLa and ATDC5 cells transfected with
a reporter construct containing the 1.0 kb SOX9 promoter, RelA
(NF-κB p65), an NF-κB family member, most strongly activated the
promoter activity. RelA and SOX9 were well co-localized in rest-
ing, pre-hypertrophic and hypertrophic chondrocytes of the limb
cartilage. The deletion, mutagenesis, and tandem-repeat analyses
of the luciferase assay in HeLa and ATDC5 cells co-transfected
with RelA or the control EV identiﬁed the core region responsive
to RelA between -266 and -228 bp relative to the transcriptional
start site of the human SOX9 gene. This region contained the
NF-κB motif which was the only fully-matched sequence in the
proximal SOX9 promoter. EMSA revealed the complex formation
of the in vitro-translated RelA protein with the 39 bp NF-κB motif
oligonucleotide probe, and the speciﬁcity was conﬁrmed by the
probe mutagenesis, the cold competition with excess amounts of
wild-type and mutated unlabelled probes, and the supershift by
addition of an antibody to RelA. ChIP assay conﬁrmed the in vivo
speciﬁc binding of RelA and the NF-κB motif, which was abolished
when using non-immune IgG or a primer set that does not span
the NF-kB motif. The RelA overexpression in HeLa and ATDC5
cells stimulated the chondrogenic differentiation parameters and
promoter activities of SOX6 and COL2A1 genes, as compared to
the control EV. Finally, the RelA-/- mice exhibited dwarﬁsm from
embryonic stages with about a half lengths of limbs and trunks
compared to those of the wild-type littermates (E15.5), which
was associated with suppression of several steps of chondrogenic
differentiation.
Conclusions: We have identiﬁed RelA as a transcriptional factor
for SOX9 induction via binding to an NF-κB binding motif in the
promoter. The RelA/SOX9 signal is essential for chondrogenic
differentiation and skeletal growth.
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Purpose: Osteoarthritis (OA) is a degenerative joint disease char-
acterized by cartilage degeneration, synovial inﬂammation, and
bone changes. In clinical end stage OA subchondral bone scle-
roses is frequently present, represented by an increased volume
of trabecular bone and cortical plate. However, in animal models
where early features of OA are studied, trabecular bone volume
and plate thickness decreases. It is unclear whether these early
changes are intrinsic to the osteoarthritis process and indepen-
dent of the cause of OA induction. Alternatively, they might be
caused by a change in joint mechanics and are related to kind of
model used. In this study, early bone changes in different canine
models of OA are evaluated in relation to cartilage changes and
mechanical variables.
Methods: Epiphyseal and metaphyseal bone changes were eval-
uated by micro-CT in the canine bilateral ACLT model (n=6),
the bilateral Groove model (n=6) and the unilateral ACLT medial
meniscectomy model (n=13), after 20, 20 and 12 weeks of OA
induction respectively. Cartilage damage was evaluated by his-
tology and proteoglycan content levels. In addition, in the two
bilateral models hydroxylysylpyridinoline (HP) and lysylpyridinoline
(LP) levels in urine were evaluated over time as indication of bone
resorption.
Results: The subchondral plate thickness decreased in both bi-
lateral models, reﬂected by an increased bone resorption shortly
after operation. However, trabecular bone changes occurred only
in the ACLT model and extended to the metaphyseal bone, which
suggests a causative relation with joint (un)loading. Cartilage dam-
age was similar in the bilateral ACLT and Groove model. In the
unilateral ACLT medial meniscectomy model, cartilage changes
were more severe on the medial side, while on the lateral (less
loaded) side trabecular bone changes were more severe. Inter-
estingly, thinning of the subchondral plate was not present on the
lateral side, but did accompany the severe cartilage degeneration
on the medial side.
Conclusions: These results show that thinning of the subchon-
dral plate is intrinsic to the process of cartilage degeneration.
The induction of OA seems to disrupt bone production locally,
either biochemical or biomechanical, which might eventually lead
to subchondral sclerosis. In addition, trabecular bone volume de-
creased when joint loading is disturbed. The signiﬁcance of an
early decrease of plate thickness and trabecular volume in OA de-
velopment is still unclear. Previous studies postulated a protective
role of the softening of bone which results in secondary unloading
of cartilage. This concept is effectively applied in osteoarthritis
treatments like joint distraction and bisphosphonate therapy.
Acknowledgements: This study was ﬁnancially supported by the
Anna Fund and the Dutch Arthritis Association.
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Purpose: Primary hip osteoarthritis (OA) is a common cause
of disability, and costs the US and Australian economies billions
of dollars each year. There is increasing evidence that systemic
changes in the trabecular bone are an underlying cause. Differen-
tial gene expression observed between OA and controls through
microarray analysis of trabecular bone from the intertrochanteric
(IT) region has raised several candidates, including genes from
the WNT and TGFβ signalling pathways; both have established
roles in osteoblast cell biology. As such an investigation in primary
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osteoblast cultures produced using trabecular bone explants from
the IT region of female hip OA cases was undertaken, in com-
parison with age and sex matched neck of femur fracture (NOF)
cases; to elucidate the role of these genes during differentiation
and mineralisation. The fracture cases were selected as epidemi-
ological, clinical and molecular reports have shown an inverse
Figure 1. Calcium apposition and gene expression proﬁles of four genes
(WNT5B, DKK1, TGFB1 and OCN) across 42 days from three mineralising pri-
mary osteoblast cultures (P4), derived from the trabecular bone of three female
OA donors. Data are presented as mean expression normalized to GAPDH, ±
SEM of triplicate reactions, corresponding axis is speciﬁed at left side (LH) or
right side (RH).
relationship between OA and NOFs, regarding incidence, bone
density and gene expression. Three genes WNT5B, DKK1 and
TGFβ1 were selected for further assessment. Selection was based
on signiﬁcant association with OA (t-score>|3.5|, p<0.05) as well
as an elucidated role in osteoblast differentiation and mineralisa-
tion. The expression of these genes was compared to osteocalcin
(OCN) a known marker of mature mineralising osteoblasts.
Methods: Primary osteoblast cultures were generated from six
donors; three OA and three NOF cases. Cultures were passaged
and then treated with osteogenic media across a 42 day time-
course. Gene expression proﬁles were quantiﬁed using real-time
PCR; Student’s t-test was used to validate signiﬁcant differences.
Mineralisation was assessed using Alizarin red stains to visualise
and quantify calcium deposition, and energy dispersive X-ray
scans to determine calcium:phosphorous (Ca:P) ratios.
Results: Examination of OA disease candidates in this ex vivo
system has revealed peak expression of WNT5B across two OA
donors at the same time point as OCN (Fig. 1). DKK1 expression
appears to be highly variable occurring before, during and after
peak OCN expression in OA (Fig. 1). TGFβ1 expression was
suppressed following peak OCN expression in all three OA donors
(Fig. 1). Signiﬁcant variation in the comparative levels of calcium
apposition and Ca:P ratios across the time course between OA
and NOF cohorts was also observed (p<0.05).
Conclusions: The peak expression of WNT5B suggests a role
in the onset of the mature phenotype and mineralisation in OA.
The WNT pathway is known to be inhibited at the late stages
of differentiation, WNT5B is also signiﬁcantly up-regulated in OA
(t-score=3.7, p<0.05) as such this canonical antagonist may be
involved in the disease. TGFβ1 expression is associated with pro-
liferation and as expected declines in expression during the late
stages of differentiation concurrent with increased OCN expres-
sion, it is down-regulated in OA (t-score=-6.9, p<0.05) as such
the levels of TGFβ1 expression may be aberrant. The variable
OA Ca content and composition of mineral ex vivo may reﬂect
the heterogeneity observed in OA pathology. Further studies will
continue to elucidate the role of WNT and TGFβ signalling in os-
teoblast differentiation and its effects on mineralisation facilitating
the identiﬁcation of potential diagnostic and therapeutic targets
against OA pathogenesis.
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Purpose: There is little evidence to guide physicians when dis-
cussing future likelihood of knee arthroplasty with patients who
have symptomatic knee osteoarthritis. Data from Osteoarthritis
Initiative (OAI) was used to determine the incidence of and predic-
tors for knee arthroplasty among patients with symptomatic knee
osteoarthritis.
Methods: OAI data were collected on a sample of 778 persons
aged 45 to 79 years with symptomatic knee osteoarthritis. An
extensive set of measurements were obtained at baseline and
persons were followed for 2 years to identify who underwent knee
arthroplasty. Random forest analysis, an advanced Classiﬁcation
and Regression Tree approach was used to identify optimal vari-
ables that discriminate among those who did and those who did
not undergo knee arthroplasty.
Results: The two year incidence of knee arthroplasty in the cohort
